Pharmaceutical and therapeutic equivalence study of the generic medicine containing loxoprofen sodium

Susumu Kaneshige, Koyanagi Satoru, Mami Kobayashi, Shigehiro Ohdo, Matsunaga Naoya, Hidetoshi Kamimura

Research output: Contribution to journalArticle

Abstract

Objectives: The use of generic medicines is generally recommended for reducing medical costs. However, many doctors and pharmacists do not trust the quality, efficacy and safety of some generic medicines. Loxonin® containing loxoprofen sodium is widely used as an antipyretics analgesic, and Lobu® is the generic form of Loxonin® The pharmaceutical and therapeutic equivalence of Lobu® was compared to Loxonin® Methods: The dissolution rate of loxoprofen sodium from Lobu® was compared to that of Loxonin®. In addition, clinical data of the patients treated with Lobu® in Fukuoka Memorial Hospital was compared to those treated with Loxonin® in Fukuoka University Chikushi Hospital. The number of patients treated with Lobu® and Loxonin® was 76 and 79, and the mean age was 45.8 years old and 47.5 years old, respectively. Results: Lobu® did not meet the standard of the dissolution test of loxoprofen sodium at a pH of 1.2. However, the analgesic effect of Lobu® on patients undergone orthopedic surgery was equal to that of Loxonin®. In addition, severe hematopoietic injury, hepatic dysfunction, or renal dysfunction were not observed during Lobu® treatment. Conclusions: Although Lobu® is not 100% pharmaceutically equivalent to Loxonin® the efficacy and safety are considered to be equivalent to Loxonin®.

Original languageEnglish
Pages (from-to)1081-1088
Number of pages8
JournalJapanese Pharmacology and Therapeutics
Volume40
Issue number12
Publication statusPublished - 2012

Fingerprint

Medicine
Analgesics
Pharmaceutical Preparations
Safety
Antipyretics
Pharmacists
Orthopedics
Therapeutics
Kidney
Costs and Cost Analysis
Liver
Wounds and Injuries
loxoprofen

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology

Cite this

Pharmaceutical and therapeutic equivalence study of the generic medicine containing loxoprofen sodium. / Kaneshige, Susumu; Satoru, Koyanagi; Kobayashi, Mami; Ohdo, Shigehiro; Naoya, Matsunaga; Kamimura, Hidetoshi.

In: Japanese Pharmacology and Therapeutics, Vol. 40, No. 12, 2012, p. 1081-1088.

Research output: Contribution to journalArticle

@article{8c411de7201c49108b12c1313a5ec5b1,
title = "Pharmaceutical and therapeutic equivalence study of the generic medicine containing loxoprofen sodium",
abstract = "Objectives: The use of generic medicines is generally recommended for reducing medical costs. However, many doctors and pharmacists do not trust the quality, efficacy and safety of some generic medicines. Loxonin{\circledR} containing loxoprofen sodium is widely used as an antipyretics analgesic, and Lobu{\circledR} is the generic form of Loxonin{\circledR} The pharmaceutical and therapeutic equivalence of Lobu{\circledR} was compared to Loxonin{\circledR} Methods: The dissolution rate of loxoprofen sodium from Lobu{\circledR} was compared to that of Loxonin{\circledR}. In addition, clinical data of the patients treated with Lobu{\circledR} in Fukuoka Memorial Hospital was compared to those treated with Loxonin{\circledR} in Fukuoka University Chikushi Hospital. The number of patients treated with Lobu{\circledR} and Loxonin{\circledR} was 76 and 79, and the mean age was 45.8 years old and 47.5 years old, respectively. Results: Lobu{\circledR} did not meet the standard of the dissolution test of loxoprofen sodium at a pH of 1.2. However, the analgesic effect of Lobu{\circledR} on patients undergone orthopedic surgery was equal to that of Loxonin{\circledR}. In addition, severe hematopoietic injury, hepatic dysfunction, or renal dysfunction were not observed during Lobu{\circledR} treatment. Conclusions: Although Lobu{\circledR} is not 100{\%} pharmaceutically equivalent to Loxonin{\circledR} the efficacy and safety are considered to be equivalent to Loxonin{\circledR}.",
author = "Susumu Kaneshige and Koyanagi Satoru and Mami Kobayashi and Shigehiro Ohdo and Matsunaga Naoya and Hidetoshi Kamimura",
year = "2012",
language = "English",
volume = "40",
pages = "1081--1088",
journal = "Japanese Pharmacology and Therapeutics",
issn = "0386-3603",
publisher = "Life Science Publishing Co. Ltd",
number = "12",

}

TY - JOUR

T1 - Pharmaceutical and therapeutic equivalence study of the generic medicine containing loxoprofen sodium

AU - Kaneshige, Susumu

AU - Satoru, Koyanagi

AU - Kobayashi, Mami

AU - Ohdo, Shigehiro

AU - Naoya, Matsunaga

AU - Kamimura, Hidetoshi

PY - 2012

Y1 - 2012

N2 - Objectives: The use of generic medicines is generally recommended for reducing medical costs. However, many doctors and pharmacists do not trust the quality, efficacy and safety of some generic medicines. Loxonin® containing loxoprofen sodium is widely used as an antipyretics analgesic, and Lobu® is the generic form of Loxonin® The pharmaceutical and therapeutic equivalence of Lobu® was compared to Loxonin® Methods: The dissolution rate of loxoprofen sodium from Lobu® was compared to that of Loxonin®. In addition, clinical data of the patients treated with Lobu® in Fukuoka Memorial Hospital was compared to those treated with Loxonin® in Fukuoka University Chikushi Hospital. The number of patients treated with Lobu® and Loxonin® was 76 and 79, and the mean age was 45.8 years old and 47.5 years old, respectively. Results: Lobu® did not meet the standard of the dissolution test of loxoprofen sodium at a pH of 1.2. However, the analgesic effect of Lobu® on patients undergone orthopedic surgery was equal to that of Loxonin®. In addition, severe hematopoietic injury, hepatic dysfunction, or renal dysfunction were not observed during Lobu® treatment. Conclusions: Although Lobu® is not 100% pharmaceutically equivalent to Loxonin® the efficacy and safety are considered to be equivalent to Loxonin®.

AB - Objectives: The use of generic medicines is generally recommended for reducing medical costs. However, many doctors and pharmacists do not trust the quality, efficacy and safety of some generic medicines. Loxonin® containing loxoprofen sodium is widely used as an antipyretics analgesic, and Lobu® is the generic form of Loxonin® The pharmaceutical and therapeutic equivalence of Lobu® was compared to Loxonin® Methods: The dissolution rate of loxoprofen sodium from Lobu® was compared to that of Loxonin®. In addition, clinical data of the patients treated with Lobu® in Fukuoka Memorial Hospital was compared to those treated with Loxonin® in Fukuoka University Chikushi Hospital. The number of patients treated with Lobu® and Loxonin® was 76 and 79, and the mean age was 45.8 years old and 47.5 years old, respectively. Results: Lobu® did not meet the standard of the dissolution test of loxoprofen sodium at a pH of 1.2. However, the analgesic effect of Lobu® on patients undergone orthopedic surgery was equal to that of Loxonin®. In addition, severe hematopoietic injury, hepatic dysfunction, or renal dysfunction were not observed during Lobu® treatment. Conclusions: Although Lobu® is not 100% pharmaceutically equivalent to Loxonin® the efficacy and safety are considered to be equivalent to Loxonin®.

UR - http://www.scopus.com/inward/record.url?scp=84873810717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873810717&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84873810717

VL - 40

SP - 1081

EP - 1088

JO - Japanese Pharmacology and Therapeutics

JF - Japanese Pharmacology and Therapeutics

SN - 0386-3603

IS - 12

ER -